ObaClin ApS: Financial statements 2025
CVR: 43789244
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ObaClin ApS (CVR 43789244) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -165,416 the year before. Equity in the 2025 report amounted to DKK -138,404.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -138,404
- Total Assets
- DKK 1,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | -138 t. | 0 |
| 2024 | - | 0 | -165 t. | -138 t. | - |
| 2023 | - | -3 t. | -13 t. | 27 t. | - |
Official annual report
How creditworthy is ObaClin ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ObaClin ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK -165,416.
About ObaClin ApS
ObaClin ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Rikke Hagmann Schmidt. The company is owned by Rikke Hagmann Schmidt. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -165,416 the year before. Equity in the 2025 report amounted to DKK -138,404.